Correlation Between ARCA Biopharma and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both ARCA Biopharma and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARCA Biopharma and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARCA Biopharma and Aerovate Therapeutics, you can compare the effects of market volatilities on ARCA Biopharma and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARCA Biopharma with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARCA Biopharma and Aerovate Therapeutics.
Diversification Opportunities for ARCA Biopharma and Aerovate Therapeutics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ARCA and Aerovate is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding ARCA Biopharma and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and ARCA Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARCA Biopharma are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of ARCA Biopharma i.e., ARCA Biopharma and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between ARCA Biopharma and Aerovate Therapeutics
If you would invest 245.00 in Aerovate Therapeutics on September 1, 2024 and sell it today you would earn a total of 18.00 from holding Aerovate Therapeutics or generate 7.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ARCA Biopharma vs. Aerovate Therapeutics
Performance |
Timeline |
ARCA Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aerovate Therapeutics |
ARCA Biopharma and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ARCA Biopharma and Aerovate Therapeutics
The main advantage of trading using opposite ARCA Biopharma and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARCA Biopharma position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.ARCA Biopharma vs. Aerovate Therapeutics | ARCA Biopharma vs. Adagene | ARCA Biopharma vs. Acrivon Therapeutics, Common | ARCA Biopharma vs. Rezolute |
Aerovate Therapeutics vs. Tff Pharmaceuticals | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Transaction History View history of all your transactions and understand their impact on performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Valuation Check real value of public entities based on technical and fundamental data |